Agoracom Blog Home

Archive for the ‘Featured’ Category

« Older Entries
Newer Entries »

VIDEO – Novamind $NM.ca Is Building the Infrastructure Required for a Regulated Psychedelics Industry $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 4:11 PM on Wednesday, February 17th, 2021

The global behavioural health market size is expected to reach approximately US$ 245 billion by 2027 and estimated to grow at CAGR of 2.5 % over the forecast time frame 2020 to 2027. 

As a consequence of the increasing incidence of mental health disorders, global demand for mental health facilities is increasing.

Psychedelics are going to go through parabolic, paradigm-shifting growth because of their ability to treat anxiety and depression amongst other things

Novamind is a leading mental health company specialized in psychedelic medicine, building the infrastructure required for a regulated psychedelics industry.

Highlights:

  • Rapidly expanding a network of outpatient mental health clinics and research sites
  • 4 clinics in Utah, 1 more anticipated this quarter
  • Provides ketamine-assisted psychotherapy and Spravato™ (esketamine) treatments;
    • Ketamine treatment volume grew 90% from 2019 to 2020
    • During the same period, total Spravato™ treatments rose 400%
  • Positioned to facilitate MDMA and psilocybin therapy post-FDA approval
  • Building centers of excellence for future approved psychedelic treatments
  • Approximately CAN$1,900,000 in 2019 revenue
  • Strong insider ownership (32.3%)

Watch this powerful interview with Dr. Reid Robison, Chief Medical Officer and Director of Novamind.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, All Recent Posts, Featured, Novamind Inc. | Comments Off on VIDEO – Novamind $NM.ca Is Building the Infrastructure Required for a Regulated Psychedelics Industry $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

CLIENT FEATURE: Novamind $NM.ca Leaders In #Psychedelic Medicine $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 11:44 AM on Friday, February 12th, 2021

NM: CSE

Why Novamind?

  • Building the infrastructure required for a regulated psychedelics industry
  • Rapidly expanding a network of outpatient mental health clinics and research sites
  • Provides ketamine-assisted psychotherapy and Spravato™ (esketamine) treatments;
    • Ketamine treatment volume grew 90% from 2019 to 2020
    • During the same period, total Spravato™ treatments rose 400%
  • Positioned to facilitate MDMA and psilocybin therapy post-FDA approval
  • Specializing in psychedelic-assisted treatment protocols
  • Building centers of excellence for future approved psychedelic treatments
  • Approximately CAN$1,900,000 in 2019 revenue
  • Strong insider ownership (32.3%) 

Yaron Conforti, CEO of Novamind Featured On Cheddar News

Novamind is focused on 3 pillars:

FULL DISCLOSURE: Novamind is an advertising client of AGORA Internet Relations Corp.

Hub On AGORACOM / Corporate Profile

Tags: , , , , , , ,
Posted in AGORACOM Client Feature, All Recent Posts, Featured, Novamind Inc. | Comments Off on CLIENT FEATURE: Novamind $NM.ca Leaders In #Psychedelic Medicine $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

ThreeD Capital Inc. $IDK.ca $IDKFF Makes $300,000 Investment Into Carl Data Solutions Inc. $CRL.ca $IP.ca $IPNFF $PKK.ca $PKKFF $MTRX $RACMF

Posted by AGORACOM-JC at 10:42 AM on Friday, February 12th, 2021
IDK-square-for-blog
  • Announced a $300,000 investment in Carl Data Solutions Inc. (CSE: CRL) (OTCQB: CDTAF), an Industrial IoT (IIoT) and Big Data as a Service (BDaaS) company that provides next generation collection, storage, and analytics solutions for data-centric organizations
  • Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated, “We are very impressed with the technology that Carl has developed that offers real world insights across industries in terms of capturing and analyzing meaningful data and providing predictive analytics, which organizations and cities can act upon. This has tremendous implication for the environment, cost-savings, and organizational and governmental efficiencies.

TORONTO, Feb. 12, 2021- ThreeD Capital Inc. (“ThreeD” or the “Company”) (CSE:IDK) (OTCQB:IDKFF), a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive technologies sectors, is pleased to announce a $300,000 investment in Carl Data Solutions Inc. (“Carl”) (CSE: CRL) (OTCQB: CDTAF), an Industrial IoT (IIoT) and Big Data as a Service (BDaaS) company that provides next generation collection, storage, and analytics solutions for data-centric organizations.

The Company has acquired 2,000,000 units (the “Units”) at a price of $0.15 per Unit for aggregate proceeds of $300,000. Each Unit consists of one (1) common share of Carl (a “Common Share”) and one Common Share purchase warrant (a “Warrant”), exercisable at a price of $0.25 per Warrant. The Warrants will expire two (2) years from the date of issuance.

Sheldon Inwentash, Chairman and CEO of ThreeD Capital stated, “We are very impressed with the technology that Carl has developed that offers real world insights across industries in terms of capturing and analyzing meaningful data and providing predictive analytics, which organizations and cities can act upon. This has tremendous implication for the environment, cost-savings, and organizational and governmental efficiencies.

Carl Data Solutions provides tools to model and predict the impact of environmental events. Using Carl’s cloud based core IT platform, Software as a Service (SaaS) applications, purpose built hardware arrays and custom data collection networks, Carl delivers end to end solutions for Industry and Government. Carl Data Solutions has invested millions of dollars into creating a technology that revolutionizes the way industries extract value from their data. Carl’s technology is now widely deployed by both Industry and Government to automate and organize data collection, storage and analysis. The demand for smart scalable solutions is growing rapidly with the explosion of new data from IoT devices. Carl is succeeding at answering the call for new ways to access and make sense of enormous amounts of data through Carl’s unique and disruptive technology.

Read More: https://agoracom.com/ir/threedcapital/forums/discussion/topics/755251-threed-capital-inc-makes-300-000-investment-into-carl-data-solutions-inc/messages/2303421#message

Tags: , , , , , , ,
Posted in Featured, ThreeD, ThreeD Capital | Comments Off on ThreeD Capital Inc. $IDK.ca $IDKFF Makes $300,000 Investment Into Carl Data Solutions Inc. $CRL.ca $IP.ca $IPNFF $PKK.ca $PKKFF $MTRX $RACMF

VIDEO – AGORACOM Beyond The Expert Welcomes Venture Capitalist Leigh Hughes To Discuss Mountain Valley MD $MVMD, Valeo Pharma $VPH $VPHIF and Xphyto Therapeutics $XPHY $XPHYF

Posted by AGORACOM-JC at 6:36 PM on Thursday, February 11th, 2021

AGORACOM followers have given us great feedback on our hit series “Beyond The Press Release” (BTPR) in which we speak with small cap CEO’s about important press releases in greater depth and, quite frankly, in layman’s terms for investors to truly understand their significance.  

Nowhere is this more important than in the world of disruptive technologies, biotech and pharma.  Each of these industries share two distinct traits:

  • The possibility for explosive growth with disruptive new products
  • Difficulty in conveying disruptive new products that, by their nature, have never been seen before by investors.

Whereas BTPR tells these stories from the side of small cap public companies, Beyond The Expert (BTE) tells these stories from the perspective of experts on these topics – and we couldn’t think of anyone better to start off this series than Leigh Hughes.  

Leigh is a Venture Capitalist who I’ve personally watched conduct incredible due diligence and invest into many small cap companies that have generated incredible returns over 12-18 month periods.    

Leigh is so good at what he does that many global private equity funds and institutions take his call and often follow him into investments he chooses to make.  Moreover, he serves as an advisor to several small cap companies.

If you ever wanted to truly learn how to become a great small cap investor, it doesn’t get much better than this.  

Without further adieu, watch this great interview with Leigh Hughes and make sure to provide us with your feedback via comments on Twitter, YouTube or wherever you may be watching or listening.

Tags: , , , , , , ,
Posted in AGORACOM Beyond The Expert, All Recent Posts, Featured, Mountain Valley MD, Valeo Pharma Inc, Xphyto Therapeutics | Comments Off on VIDEO – AGORACOM Beyond The Expert Welcomes Venture Capitalist Leigh Hughes To Discuss Mountain Valley MD $MVMD, Valeo Pharma $VPH $VPHIF and Xphyto Therapeutics $XPHY $XPHYF

Novamind $NM.ca Announces Strategic Investment in #Bionomics $BNOEF to Support #PTSD Clinical Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

Posted by AGORACOM-JC at 8:20 AM on Thursday, February 11th, 2021

Cedar Clinical Research to be Evaluated to Support Phase IIb Trial of Novel PTSD Treatment

  • Announced that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.
  • In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210.
  • BNC210 has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).

TORONTO, ON / February 11, 2021 / Novamind Inc. (CSE:NM) (“Novamind”), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has made a strategic investment of AU$827,486 (approximately CAN$810,000, the “Strategic Investment”), in Bionomics Limited (“Bionomics”) (ASX:BNO)(OTCQB:BNOEF) (Germany:AU000000BNO5), a biopharmaceutical company dedicated to developing better treatments for central nervous system disorders.

In addition, Cedar Clinical Research (“CCR”), a wholly owned subsidiary of Novamind based in Springville, Utah, will be evaluated by Bionomics as a clinical research site to conduct Bionomics’ Phase IIb trial examining BNC210. BNC210 has received Fast Track Designation from the U.S. Food and Drug Administration for the treatment of post-traumatic stress disorder (PTSD).

With its investment in Bionomics, Novamind joins a group of well-known investors that specialize in psychedelics and biotech: Apeiron Investments, Biotech Value Fund, Merck & Co., Mike Novogratz, and Peter Thiel, an early investor in ATAI Life Sciences.

Novamind’s Strategic Investment is included in Bionomics’ latest round of financing, which was underwritten by Apeiron Investments and received commitments for AU$16,000,000 (approximately CAN$15,680,000, the “Bionomics Financing”). Novamind will purchase a total of 5,706,800 common shares in the Bionomics Financing, at AU$0.145 per share, a 20% discount to the 30-day volume weighted average price as of February 5th, 2021. Proceeds from the Bionomics Financing will support the initiation of a Phase IIb trial for BNC210, planned for mid-2021.

Bionomics intends to evaluate Cedar Clinical Research’s deep expertise in facilitating Phase I to Phase IV clinical trials for leading pharmaceutical companies, and how it may potentially serve as a research site for Bionomics’ Phase IIb clinical trial examining BNC210 in PTSD patients.

Cedar Clinical Research, led by Novamind’s Chief Medical Officer, Dr. Reid Robison, is currently contracted for seven clinical trials with various sponsors, including leading pharmaceutical companies. Dr. Robison has led over 100 clinical trials in neuropsychiatry, researching a spectrum of psychiatric conditions, including PTSD.

“I’m happy to welcome Novamind as a strategic investor in Bionomics,” said Dr. Errol De Souza, Executive Chairman of Bionomics. “Dr. Robison and the team at Cedar Clinical Research have unique experience related to clinical trials for mental health therapeutics.”

Yaron Conforti, CEO and Director of Novamind, added, “We are pleased to participate in Bionomics’ financing to support the development of its novel drug candidate for the treatment of PTSD. Cedar Clinical Research has unique expertise in PTSD research, and we look forward to the opportunity to contribute to the development of BNC210.”

To learn more about Cedar Clinical Research, please visit cedarclinicalresearch.com.

About Bionomics

Bionomics is a global, clinical stage biopharmaceutical company leveraging its proprietary platform technologies to discover and develop a deep pipeline of best in class, novel drug candidates. Bionomics’ lead drug candidate BNC210, currently in development for initiation of a second Phase II trial for the treatment of PTSD, is a novel, proprietary negative allosteric modulator of the alpha-7 (α7) nicotinic acetylcholine receptor. Beyond BNC210, Bionomics has a strategic partnership with Merck & Co., Inc (known as MSD outside the United States and Canada). To learn more, please visit bionomics.com.au.

About Novamind

Novamind is a leading mental health company enabling safe access to psychedelic medicine through a network of clinics, retreats, and clinical research sites. Novamind provides ketamine-assisted psychotherapy and other novel treatments through its network of Cedar Psychiatry clinics and operates Cedar Clinical Research, a contract research organization specialized in clinical trials and evidence-based research for psychedelic medicine. Both Cedar Psychiatry and Cedar Clinical Research are wholly owned subsidiaries of Novamind. For more information on how Novamind is enhancing mental wellness and guiding people through their entire healing journey, visit novamind.ca.

Contact Information

Novamind
Yaron Conforti, CEO and Director
Telephone: +1 (647) 953 9512
Bill Mitoulas, Investor Relations
Email: [email protected]

Forward-Looking Statements

This news release contains forward-looking statements. All statements other than statements of historical fact included in this release are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations including the risks detailed from time to time in the Company’s public disclosure. The reader is cautioned not to place undue reliance on any forward-looking information. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and the Company will update or revise publicly any of the included forward-looking statements as expressly required by applicable laws.

SOURCE: Novamind Inc.

Read More: https://agoracom.com/ir/Novamind/forums/discussion/topics/755165-novamind-announces-strategic-investment-in-bionomics-to-support-ptsd-clinical-trial/messages/2303206#message

Tags: , , , , , , , ,
Posted in Featured, Novamind Inc. | Comments Off on Novamind $NM.ca Announces Strategic Investment in #Bionomics $BNOEF to Support #PTSD Clinical Trial $RVV.ca $MMED $PSYC.ca $FTRP.ca $CMPS $NUMI.ca

VIDEO – PyroGenesis $PYR.ca Goes Live For Q&A With Shareholders As Market Cap Surpasses $1 BILLION

Posted by AGORACOM-JC at 6:02 PM on Tuesday, February 9th, 2021

To say that PyroGenesis Canada (PYR:TSX) and its CEO, Peter Pascali, share a mutual love and respect with shareholders unlike anything we have ever seen is not an overstatement.  

This is a group (Company, CEO and Shareholders) that have been through the highs and lows of PyroGenesis over the years TOGETHER.  That bond only got tighter when Pascali took to the PYR Verified Forum on AGORACOM to speak with investors directly and openly with his first ever post on June 21, 2017 followed by more than 20 in-depth videos in which he took his engagement with investors even deeper by answering every single question possible to the best of his ability.  

Knowing this, it should not surprise anybody learning about PyroGenesis for the first time that shareholders have coined the rallying call of “In Peter We Trust”.  

Today PyroGenesis, Pascali and shareholders shared another major milestone together in a live Q&A that coincided with PyroGenesis surpassing a $1 BILLION MARKET CAP.  It was an incredibly special event that could not be made clearer than by many of the questions and comments that referred not just to the Company’s bottom – but to its soul and philosophy.    

I’ve never seen it before.  All I can say is that it is a thrill to be witness to and part of something this deeply special in an industry that rarely looks beyond the next quarter.  

Congratulations to Peter, the Pyro team and this incredible group of shareholders.  

George and the AGORACOM team.  

Watch, listen and enjoy today’s interview with CEO Peter Pascali.

Tags: , , , , ,
Posted in AGORACOM Via Satellite, Featured, PyroGenesis Canada Inc. | Comments Off on VIDEO – PyroGenesis $PYR.ca Goes Live For Q&A With Shareholders As Market Cap Surpasses $1 BILLION

VIDEO – Loop Insights $MTRX $RACMF Lands First Multi-Million $ Deal Through #TELUS $T.ca $TU Partnership $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 4:37 PM on Monday, February 8th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Topics we discuss:

  • 4-Year multi-million COVID19 VenueBubble deal with Big White Ski Resort
  • Deal via Telus
  • IoT Partnership
  • UK Pilot Deals
  • New CTO from NTT DATA
  • Re-Open Vancouver with Empower Clinics

Tags: , , , , , , , , ,
Posted in Featured, Loop Insights Inc. | Comments Off on VIDEO – Loop Insights $MTRX $RACMF Lands First Multi-Million $ Deal Through #TELUS $T.ca $TU Partnership $SNSR $BSQR $PTS.ca

@DraganflyInc $DFLY.ca $DFLYF Interview to Air on @Bloomberg International on the RedChip Money Report $FLT.ca $UAVS $ALPP

Posted by AGORACOM-JC at 9:27 AM on Friday, February 5th, 2021
http://blog.agoracom.com/wp-content/uploads/2021/01/4s2LNj7D.jpg
  • Announced an interview with CEO Cameron Chell will air on The RedChip Money Report on Bloomberg International on Sunday, February 7, 2021 at 6 p.m. local time across Europe.
  • The RedChip Money Report airs on Bloomberg Television U.S. on Saturdays at 7 p.m. local time in 73 million homes and on the Bloomberg Network in Europe in 100 million homes at 6 pm local time on Sundays.

Los Angeles, Feb. 05, 2021 — Draganfly Inc. (OTCQB: DFLYF) (CSE: DFLY) (FSE: 3U8) (“Draganfly” or the “Company”), an award-winning, industry-leading drone solutions and systems developer, today announced an interview with CEO Cameron Chell will air on The RedChip Money Report on Bloomberg International on Sunday, February 7, 2021 at 6 p.m. local time across Europe. The RedChip Money Report airs on Bloomberg Television U.S. on Saturdays at 7 p.m. local time in 73 million homes and on the Bloomberg Network in Europe in 100 million homes at 6 pm local time on Sundays.

In the exclusive interview, Mr. Chell discusses Draganfly’s specialization in drones, sensors, and AI, the rapidly growing drone market, and Draganfly’s wide range of lucrative applications for breakthrough spectral imaging technology.

“The RedChip Money Report” delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.

Read More: https://agoracom.com/ir/Draganfly/forums/discussion/topics/754758-draganfly-inc-interview-to-air-on-bloomberg-international-on-the-redchip-money-report/messages/2302260#message

Tags: , , , , ,
Posted in Draganfly Inc., Featured | Comments Off on @DraganflyInc $DFLY.ca $DFLYF Interview to Air on @Bloomberg International on the RedChip Money Report $FLT.ca $UAVS $ALPP

Datametrex $DM.ca $DTMXF Announces Another COVID-19 Test Kit Sales to Canadian Mining Company $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:59 AM on Monday, February 1st, 2021
  • Received a Purchase Order from a Canadian mining company for COVID-19 test kits manufactured by 1drop Inc., and ancillary products.
  • The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees.
  • This brings approximately $2.8M sales to date to the Canadian mining companies.

Toronto, Ontario–(February 1, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”), is pleased to announce that it has received a Purchase Order (the “PO”) from a Canadian mining company (the “Purchaser”) for COVID-19 test kits manufactured by 1drop Inc. (“1drop”), and ancillary products. The total gross sales amount of the sales is approximately $250,000 CAD, excluding shipping and courier fees. This brings approximately $2.8M sales to date to the Canadian mining companies.

Under the terms of the sale to the Purchaser, Datametrex will provide 1drop COVID-19 qPCR Detection Kits, a PCR machine, an RNA extraction machine, and RNA extraction kits. Datametrex anticipates that it has a little or no upfront costs associated with the sale of the test kits. All of the items are shipped directly from manufacturers to the purchaser’s mine operating sites.

“This further confirms Datametrex’s approach with its diverse COVID-19 product portfolio of health security products and services,” stated Marshall Gunter, CEO of Datametrex.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/754315-datametrex-announces-another-covid-19-test-kit-sales-to-canadian-mining-company/messages/2301339#message

Tags: , , , , , , , ,
Posted in Datametrex AI Limited, Featured | Comments Off on Datametrex $DM.ca $DTMXF Announces Another COVID-19 Test Kit Sales to Canadian Mining Company $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

The Ties That Bind GameStop $GME To PlantX Life $VEGA.ca $PLTXF $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

Posted by AGORACOM-JC at 2:30 PM on Wednesday, January 27th, 2021

As many of you have been watching the astounding rise of GameStop (GME:NASDAQ) it’s hard not to take notice of a company whose stock has had a 52-week low of $2.57 to a recent high of $380.

You may ask what a Fortune 500 company and a digital-first omni-channel retailer who offers games and entertainment products in its over 5,000 stores and comprehensive e-commerce properties across 10 countries has in common with PlantX Life Inc. (the “Company” or “PlantX”) (VEGA:CSE) (PLTXF:OTC) an online/ brick and mortar one-stop-shop for everything plant-based has in common…

It’s simple. Ryan Cohen, GameStop (GME:NASDAQ) inside shareholder, Board Member and… Sean Dollinger, founder of PlantX Life (VEGA:CSE) (PLTXF:OTC).  The relationship runs deep. Ryan Cohen and Sean Dollinger were 50/50 partners on 3 .coms. After the three websites, Cohen went on to start Chewy.com and Dollinger went on to start Namaste Technologies. Cohen exited Chewy.com with a highly publicized sale to (Petsmart (PETM: NASDAQ), Dollinger brought Namaste Technologies to a $1.2B market cap. 

In August of 2020, Ryan Cohen stepped into GameStop (GME:NASDAQ), took a sizable position in the company (~12%) and obtained 3 board seats. The stock instantly attracted a cult-like following. As a result, the company’s shares went from $4 to over $380.

Sean Dollinger founded PlantX in December 2019. As of April 2020 the Company had no revenue to speak of. Fast forward 8 months to December 2020 and PlantX Life (VEGA:CSE) (PLTXF:OTC) generated gross monthly revenue of over $1M for the month. It’s interesting to point out that Cohen and Dollinger have very similar prowess especially within the e-commerce space. After-all, they learned everything about e-commerce together, and then went on their own paths to both build billion dollar e-commerce companies using the strategies they learned together.

PlantX Life (VEGA:CSE) (PLTXF:OTC) maintains a first mover advantage as the first (known) public company fully focused on the plant-based e-commerce space.   The Company exhibits strong fundamentals with cash on balance sheet, no debt, low CapEx requirements and diverse revenue streams. The Company operates in three high-growth industries – the plant-based, e-commerce/technology and consumer-packaged goods sectors. PlantX continues strides for global reach with their intent to list on Nasdaq,  evidence of the company’s commitment to investor accessibility and corporate growth.

Source: https://agoracom.com/ir/PlantX/forums/discussion/topics/754060-the-ties-that-bind-gamestop-to-plantx-life/messages/2300611#message

Tags: , , , , , , , , ,
Posted in All Recent Posts, Featured, Plant-Based Food, PlantX Life Inc. | Comments Off on The Ties That Bind GameStop $GME To PlantX Life $VEGA.ca $PLTXF $VERY.ca $MEAT.ca $EATS.ca $VEGN.ca

« Older Entries
Newer Entries »